Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response
E. Dreesen; T. Van Stappen; V. Ballet; M. Peeters; G. Compernolle; S. Tops; K. Van Steen; G. Van Assche; M. Ferrante; S. Vermeire; A. Gils
Author Information: Laboratory for Therapeutic and Diagnostic Antibodies
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.